Correlation Between Lineage Cell and Graphite Bio
Can any of the company-specific risk be diversified away by investing in both Lineage Cell and Graphite Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and Graphite Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lineage Cell Therapeutics and Graphite Bio, you can compare the effects of market volatilities on Lineage Cell and Graphite Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of Graphite Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and Graphite Bio.
Diversification Opportunities for Lineage Cell and Graphite Bio
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Lineage and Graphite is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and Graphite Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Graphite Bio and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with Graphite Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Graphite Bio has no effect on the direction of Lineage Cell i.e., Lineage Cell and Graphite Bio go up and down completely randomly.
Pair Corralation between Lineage Cell and Graphite Bio
If you would invest 267.00 in Graphite Bio on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Graphite Bio or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Lineage Cell Therapeutics vs. Graphite Bio
Performance |
Timeline |
Lineage Cell Therapeutics |
Graphite Bio |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lineage Cell and Graphite Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lineage Cell and Graphite Bio
The main advantage of trading using opposite Lineage Cell and Graphite Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, Graphite Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Graphite Bio will offset losses from the drop in Graphite Bio's long position.Lineage Cell vs. MAIA Biotechnology | Lineage Cell vs. Armata Pharmaceuticals | Lineage Cell vs. Portage Biotech | Lineage Cell vs. Cadrenal Therapeutics, Common |
Graphite Bio vs. Assembly Biosciences | Graphite Bio vs. Instil Bio | Graphite Bio vs. Nuvation Bio | Graphite Bio vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |